Contents
© National Blood Authority, 2012.
With the exception of any logos and registered trademarks, and where otherwise noted, all material presented in this document is provided under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Australia (http://creativecommons.org/licenses/by-nc-sa/3.0/au/) licence.
You are free to copy, communicate and adapt the work for non-commercial purposes, as long as you attribute the authors and distribute any derivative work (i.e. new work based on this work) only under this licence.
If you adapt this work in any way or include it in a collection, and publish, distribute or otherwise disseminate that adaptation or collection to the public, it should be attributed in the following way:
This work is based on/includes The National Blood Authority’s Patient Blood Management Guideline: Module 3 – Medical which is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Australia licence.
Where this work is not modified or changed, it should be attributed in the following way:
© National Blood Authority, 2012.
ISBN 978-0-9872519-8-5
For more information:
Patient Blood Management Guidelines National Blood Authority
Locked Bag 8430
Canberra ACT 2601
Telephone: (02) 6151 5000
Email: guidelines@blood.gov.au
Website: www.blood.gov.au
Disclaimer
This document is a general guide to appropriate practice, to be followed subject to the circumstances, clinician’s judgement and patient’s preferences in each individual case. It is designed to provide information to assist decision making. Recommendations contained herein are based on the best available evidence published between 1966 and July 2010. The relevance and appropriateness of the information and recommendations in this document depend on the individual circumstances. Moreover, the recommendations and guidelines are subject to change over time.
Each of the parties involved in developing this document expressly disclaims and accepts no responsibility for any undesirable consequences arising from relying on the information or recommendations contained herein.
Publication approval
These guidelines were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 18 July 2012, under Section 14A of the National Health and Medical Research Council Act 1992. In approving these guidelines the NHMRC considers that they meet the NHMRC standard for clinical practice guidelines. This approval is valid for a period of five years.
NHMRC is satisfied that they are based on the systematic identification and synthesis of the best available scientific evidence and make clear recommendations for health professionals practising in an Australian health care setting. The NHMRC expects that all guidelines will be reviewed no less than once every five years.
This publication reflects the views of the authors and not necessarily the views of the Australian Government.
Funding and project management
Funding, Secretariat and Project Management was provided by the National Blood Authority Australia. The systematic review methods, writing of the document or development of the final recommendations and practice points have not been influenced by the views or interests of the funding body.